Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| FORUM MARKETS IncATNF · Entity 7020 | Director | September 04, 2023 | September 08, 2023 |
| LifeStance Health Group, Inc.LFST · Entity 3936 | Director | August 14, 2026 | August 18, 2026 |
| Surgery Partners, Inc.SGRY · Entity 4534 | Director | August 18, 2026 | August 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
FORUM MARKETS Inc
Report date September 04, 2023 · Filed September 08, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.67 · Expires 2033-09-04 | Direct | 15,000 |
Reported balance
After 2023-09-04 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2023-09-04 · Grant · Acquired 15,000 · Balance 15,000 F3: Granted in consideration for services rendered and to be rendered as a member of the Board of Directors for the quarter ended June 30, 2023. Granted under the registrant's First Amended and Restated 2022 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3. F4: The options vest at the rate of 1/12th of such options ratably on a monthly basis over the following 12 months on the last day of each calendar month (beginning September 30, 2023), subject to the Reporting Person's continued service to the Company on such vesting dates. |
| Common StockSEC Table I · non-derivative | Direct | 250 |
Reported balance
Holding disclosure · report date 2023-09-04 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 250 |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 125 |
Reported balance
Holding disclosure · report date 2023-09-04 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 125 F1: Shares are held by The Santina Iraggi Irrvoc TR, U/A 11/2/20, an irrevocable trust, of which the Reporting Person is beneficiary and trustee. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 125 |
Reported balance
Holding disclosure · report date 2023-09-04 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 125 F2: Shares are held by the REV TR FBO Teresa M Deluca, a revocable trust, of which the Reporting Person is beneficiary and trustee. |
| Common StockSEC Table I · non-derivative | IndirectBy Spouse | 125 |
Reported balance
Holding disclosure · report date 2023-09-04 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 125 |
Filing footnotes · ownership attribution and instrument terms
F1: Shares are held by The Santina Iraggi Irrvoc TR, U/A 11/2/20, an irrevocable trust, of which the Reporting Person is beneficiary and trustee.
F2: Shares are held by the REV TR FBO Teresa M Deluca, a revocable trust, of which the Reporting Person is beneficiary and trustee.
F3: Granted in consideration for services rendered and to be rendered as a member of the Board of Directors for the quarter ended June 30, 2023. Granted under the registrant's First Amended and Restated 2022 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3.
F4: The options vest at the rate of 1/12th of such options ratably on a monthly basis over the following 12 months on the last day of each calendar month (beginning September 30, 2023), subject to the Reporting Person's continued service to the Company on such vesting dates.
LifeStance Health Group, Inc.
Report date August 14, 2026 · Filed August 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 97,093 |
Reported balance
After 2026-08-14 transaction · row 1
1 source rowRow 1 · 2026-08-14 · Sale · Disposed 7,500 · Balance 97,093 F1: Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $12.68 to $12.695 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
Filing footnotes · ownership attribution and instrument terms
F1: Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
F2: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $12.68 to $12.695 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Surgery Partners, Inc.
Report date August 18, 2026 · Filed August 20, 2026 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 68,093 |
Reported balance
After 2026-08-18 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2026-08-18 · Purchase · Acquired 11,250 · Balance 68,093 F1: The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. F2: This Form 4/A amends the Form 4 originally filed on August 19, 2026 to correct the number of shares of the Issuer's common stock purchased by the Reporting Person and the purchase price per share reported in Table I. The original Form 4 inadvertently reported the purchase of 10,000 shares at a price of $14.35 per share. The Reporting Person actually purchased 11,250 shares at a price of $14.33 per share. The amount of securities beneficially owned following the transaction has been corrected accordingly. Except as set forth herein, the original Form 4 remains unchanged. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.
F2: This Form 4/A amends the Form 4 originally filed on August 19, 2026 to correct the number of shares of the Issuer's common stock purchased by the Reporting Person and the purchase price per share reported in Table I. The original Form 4 inadvertently reported the purchase of 10,000 shares at a price of $14.35 per share. The Reporting Person actually purchased 11,250 shares at a price of $14.33 per share. The amount of securities beneficially owned following the transaction has been corrected accordingly. Except as set forth herein, the original Form 4 remains unchanged.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 18, 2026 Filed Aug 19, 2026 20:17 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | PurchaseCommon Stock | 10,000 | $14.35 | $143,500.00 |
DisclosureSEC source: 0001638833-26-000079 · wk-form4_1787170661.xml · nonDerivative · entry 1 DeLuca Teresa · CIK 0001685627 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,843 F1 · price: The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 18, 2026 Filed Aug 20, 2026 22:10 UTC Amendment | Surgery Partners, Inc. SGRY · Entity 4534 | PurchaseCommon Stock | 11,250 | $14.33 | $161,212.50 |
DisclosureSEC source: 0001638833-26-000081 · wk-form4a_1787263825.xml · nonDerivative · entry 1 DeLuca Teresa · CIK 0001685627 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,093 F1 · price: The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. F2 · balance_after: This Form 4/A amends the Form 4 originally filed on August 19, 2026 to correct the number of shares of the Issuer's common stock purchased by the Reporting Person and the purchase price per share reported in Table I. The original Form 4 inadvertently reported the purchase of 10,000 shares at a price of $14.35 per share. The Reporting Person actually purchased 11,250 shares at a price of $14.33 per share. The amount of securities beneficially owned following the transaction has been corrected accordingly. Except as set forth herein, the original Form 4 remains unchanged. Read SEC document |
| August 14, 2026 Filed Aug 18, 2026 21:13 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | SaleCommon Stock | 7,500 | $12.68 | $95,100.00 |
DisclosureSEC source: 0001193125-26-355681 · ownership.xml · nonDerivative · entry 1 DeLuca Teresa · CIK 0001685627 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,093 F1 · kind: Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · shares: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $12.68 to $12.695 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 13, 2026 Filed Aug 14, 2026 21:48 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | SaleCommon Stock | 20,441 | $12.23 | $249,993.43 |
DisclosureSEC source: 0001193125-26-352699 · ownership.xml · nonDerivative · entry 1 DeLuca Teresa · CIK 0001685627 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,593 Read SEC document |
| July 02, 2026 Filed Jul 7, 2026 23:38 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | GrantCommon Stock | 17,746 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-297802 · ownership.xml · nonDerivative · entry 1 DeLuca Teresa · CIK 0001685627 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,034 F1 · shares: Includes 17,746 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| June 05, 2026 Filed Jun 9, 2026 20:27 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | GrantCommon Stock | 11,670 | $13.71 | $159,995.70 |
DisclosureSEC source: 0001638833-26-000058 · wk-form4_1781036863.xml · nonDerivative · entry 1 DeLuca Teresa · CIK 0001685627 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,843 F1 · shares: Shares will vest on June 5, 2027. Read SEC document |
| August 11, 2025 Filed Aug 15, 2025 22:31 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | SaleCommon Stock | 20,018 | $22.74 | $455,209.32 |
DisclosureSEC source: 0001638833-25-000145 · wk-form4_1755297063.xml · nonDerivative · entry 1 DeLuca Teresa · CIK 0001685627 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,173 F1 · price: The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 11, 2025 Filed Jun 13, 2025 23:35 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | GrantCommon Stock | 35,714 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-086458 · ownership.xml · nonDerivative · entry 1 DeLuca Teresa · CIK 0001685627 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,288 F1 · shares: Includes 35,714 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| June 10, 2025 Filed Jun 12, 2025 20:26 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | GrantCommon Stock | 6,861 | $23.32 | $159,998.52 |
DisclosureSEC source: 0001638833-25-000113 · wk-form4_1749759970.xml · nonDerivative · entry 1 DeLuca Teresa · CIK 0001685627 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,191 F1 · shares: Shares will vest on June 10, 2026. Read SEC document |
| August 14, 2024 Filed Aug 30, 2024 20:30 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | GrantCommon Stock | 35,211 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-102377 · ownership.xml · nonDerivative · entry 1 DeLuca Teresa · CIK 0001685627 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,574 F1 · shares: Includes 35,211 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| July 21, 2024 Filed Aug 27, 2024 20:56 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | GrantCommon Stock | 36,363 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-101078 · ownership.xml · nonDerivative · entry 1 DeLuca Teresa · CIK 0001685627 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 36,363 F1 · shares: Includes 36,363 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2 · ownership.nature: Shares held of record by Yawaog Enterprises Corp. The Reporting Person is the controlling shareholder of Yawaog Enterprises Corp. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities on this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Exchange Act or for any other purpose. Read SEC document |
| June 06, 2024 Filed Jun 10, 2024 20:25 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | GrantCommon Stock | 6,170 | $25.93 | $159,988.10 |
DisclosureSEC source: 0001638833-24-000121 · wk-form4_1718051135.xml · nonDerivative · entry 1 DeLuca Teresa · CIK 0001685627 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,330 F1 · shares: Shares will vest on June 6, 2025. Read SEC document |
| September 04, 2023 Filed Sep 8, 2023 20:00 UTC | FORUM MARKETS Inc ATNF · Entity 7020 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $0.67 | $0.00 |
DisclosureSEC source: 0001213900-23-075378 · ownership.xml · derivative · entry 5 DeLuca Teresa · CIK 0001685627 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2033-09-04 F3 · kind: Granted in consideration for services rendered and to be rendered as a member of the Board of Directors for the quarter ended June 30, 2023. Granted under the registrant's First Amended and Restated 2022 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3. F3 · price: Granted in consideration for services rendered and to be rendered as a member of the Board of Directors for the quarter ended June 30, 2023. Granted under the registrant's First Amended and Restated 2022 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3. F4 · derivative.exercise_date: The options vest at the rate of 1/12th of such options ratably on a monthly basis over the following 12 months on the last day of each calendar month (beginning September 30, 2023), subject to the Reporting Person's continued service to the Company on such vesting dates. Read SEC document |
| June 01, 2023 Filed Apr 5, 2024 20:50 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | GrantCommon Stock | 4,192 | $38.16 | $159,966.72 |
DisclosureSEC source: 0001638833-24-000095 · wk-form4_1712350235.xml · nonDerivative · entry 1 DeLuca Teresa · CIK 0001685627 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,160 F1 · shares: Shares will vest on June 1, 2024. Read SEC document |
| November 21, 2022 Filed Nov 22, 2022 21:22 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | PurchaseCommon Stock | 20,000 | $24.50 | $490,000.00 |
DisclosureSEC source: 0001638833-22-000137 · wf-form4_166915210301564.xml · nonDerivative · entry 1 DeLuca Teresa · CIK 0001685627 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,968 F1 · shares: Represents shares purchased from the underwriters in connection with the Issuer public offering on November 21, 2022. Read SEC document |
| May 20, 2022 Filed May 24, 2022 20:13 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | GrantCommon Stock | 4,030 | $39.70 | $159,991.00 |
DisclosureSEC source: 0001638833-22-000111 · wf-form4_165342321661392.xml · nonDerivative · entry 1 DeLuca Teresa · CIK 0001685627 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,968 F1 · shares: Shares will vest on May 20, 2023. Read SEC document |
| May 19, 2022 Filed May 23, 2022 20:30 UTC | FORUM MARKETS Inc ATNF · Entity 7020 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 21,000 | $0.00 Strike: $1.36 | $0.00 |
DisclosureSEC source: 0001213900-22-028974 · ownership.xml · derivative · entry 5 DeLuca Teresa · CIK 0001685627 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 Underlying: Common Stock · 21,000 shares Expires 2032-05-19 F3 · kind: Granted in consideration for services rendered and to be rendered as a member of the Board of Directors. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3. F3 · price: Granted in consideration for services rendered and to be rendered as a member of the Board of Directors. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3. F4 · derivative.exercise_date: The Options vest at the rate of 1/39th of such options ratably on a monthly basis over the 39 months following the grant date, on the last day of each calendar month (beginning on May 31, 2022), subject to the holder's continued service to the Company. Read SEC document |
| March 24, 2022 Filed Mar 25, 2022 20:54 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | SaleCommon Stock | 1,535 | $53.50 | $82,122.50 |
DisclosureSEC source: 0001638833-22-000081 · wf-form4_164824162122972.xml · nonDerivative · entry 1 DeLuca Teresa · CIK 0001685627 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,938 Read SEC document |
| December 09, 2021 Filed Dec 13, 2021 13:35 UTC | FORUM MARKETS Inc ATNF · Entity 7020 | PurchaseCommon Stock | 2,500 | $3.95 | $9,875.00 |
DisclosureSEC source: 0001213900-21-064878 · ownership.xml · nonDerivative · entry 4 DeLuca Teresa · CIK 0001685627 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 2,500 Read SEC document |
| December 09, 2021 Filed Dec 13, 2021 13:35 UTC | FORUM MARKETS Inc ATNF · Entity 7020 | PurchaseCommon Stock | 2,500 | $3.99 | $9,975.00 |
DisclosureSEC source: 0001213900-21-064878 · ownership.xml · nonDerivative · entry 3 DeLuca Teresa · CIK 0001685627 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 2,500 F2 · ownership.nature: Shares are held by the REV TR FBO Teresa M Deluca, a revocable trust, of which the Reporting Person is beneficiary and trustee. Read SEC document |
| December 09, 2021 Filed Dec 13, 2021 13:35 UTC | FORUM MARKETS Inc ATNF · Entity 7020 | PurchaseCommon Stock | 2,500 | $3.98 | $9,950.00 |
DisclosureSEC source: 0001213900-21-064878 · ownership.xml · nonDerivative · entry 2 DeLuca Teresa · CIK 0001685627 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 2,500 F1 · ownership.nature: Shares are held by The Santina Iraggi Irrvoc TR, U/A 11/2/20, an irrevocable trust, of which the Reporting Person is beneficiary and trustee. Read SEC document |
| December 09, 2021 Filed Dec 13, 2021 13:35 UTC | FORUM MARKETS Inc ATNF · Entity 7020 | PurchaseCommon Stock | 5,000 | $4.00 | $20,000.00 |
DisclosureSEC source: 0001213900-21-064878 · ownership.xml · nonDerivative · entry 1 DeLuca Teresa · CIK 0001685627 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Read SEC document |
| August 10, 2021 Filed Aug 12, 2021 20:46 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | PurchaseCommon Stock | 2,000 | $46.70 | $93,400.00 |
DisclosureSEC source: 0001638833-21-000138 · wf-form4_162880113573089.xml · nonDerivative · entry 1 DeLuca Teresa · CIK 0001685627 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,473 Read SEC document |
| August 04, 2021 Filed Aug 5, 2021 21:18 UTC | FORUM MARKETS Inc ATNF · Entity 7020 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 79,000 | $0.00 Strike: $7.56 | $0.00 |
DisclosureSEC source: 0001213900-21-040572 · ownership.xml · derivative · entry 2 DeLuca Teresa · CIK 0001685627 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,000 Underlying: Common Stock · 79,000 shares Expires 2031-08-04 F1 · kind: Granted in consideration for services rendered and to be rendered as a member of the Board of Directors. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 promulgated under the Exchange Act. F1 · price: Granted in consideration for services rendered and to be rendered as a member of the Board of Directors. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 promulgated under the Exchange Act. F2 · derivative.exercise_date: The Options vest at the rate of 1/48th of such options ratably on a monthly basis over the following 48 months following the grant date, on the last day of each calendar month (beginning on August 31, 2021), subject to the holder's continued service to the Company. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 20:30 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | SaleCommon Stock | 5,035 | $63.67 | $320,578.45 |
DisclosureSEC source: 0001638833-21-000130 · wf-form4_162344340972962.xml · nonDerivative · entry 1 DeLuca Teresa · CIK 0001685627 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,473 Read SEC document |
| June 08, 2021 Filed Jun 9, 2021 21:36 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | SaleCommon Stock | 2,633 | $63.05 | $166,010.65 |
DisclosureSEC source: 0001638833-21-000128 · wf-form4_162327457446052.xml · nonDerivative · entry 1 DeLuca Teresa · CIK 0001685627 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,508 Read SEC document |
| March 10, 2021 Filed Mar 15, 2021 16:09 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | GrantCommon Stock | 3,330 | $0.00 | $0.00 |
DisclosureSEC source: 0001638833-21-000057 · wf-form4_161582457931374.xml · nonDerivative · entry 1 DeLuca Teresa · CIK 0001685627 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,141 F1 · shares: Shares will vest on March 10, 2022. Read SEC document |
| December 14, 2020 Filed Dec 15, 2020 20:11 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | SaleCommon Stock | 1,000 | $27.15 | $27,150.00 |
DisclosureSEC source: 0001638833-20-000079 · wf-form4_160806308876518.xml · nonDerivative · entry 1 DeLuca Teresa · CIK 0001685627 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,811 Read SEC document |
| December 04, 2020 Filed Dec 7, 2020 16:25 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | SaleCommon Stock | 915 | $27.75 | $25,391.25 |
DisclosureSEC source: 0001638833-20-000077 · wf-form4_160735834441552.xml · nonDerivative · entry 1 DeLuca Teresa · CIK 0001685627 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,811 Read SEC document |
| December 01, 2020 Filed Dec 2, 2020 21:06 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,199 | $0.00 Strike: $20.24 | $0.00 |
DisclosureSEC source: 0001638833-20-000075 · wf-form4_160694317481575.xml · derivative · entry 3 DeLuca Teresa · CIK 0001685627 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,199 shares Expires 2026-09-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2020 Filed Dec 2, 2020 21:06 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | Tax withholdingCommon Stock | 3,284 | $25.88 | $84,989.92 |
DisclosureSEC source: 0001638833-20-000075 · wf-form4_160694317481575.xml · nonDerivative · entry 2 DeLuca Teresa · CIK 0001685627 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,726 Read SEC document |
| December 01, 2020 Filed Dec 2, 2020 21:06 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | Exercise / conversionCommon Stock | 4,199 | $20.24 | $84,987.76 |
DisclosureSEC source: 0001638833-20-000075 · wf-form4_160694317481575.xml · nonDerivative · entry 1 DeLuca Teresa · CIK 0001685627 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,010 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 10, 2020 Filed Sep 14, 2020 17:08 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | SaleCommon Stock | 3,000 | $21.00 | $63,000.00 |
DisclosureSEC source: 0001638833-20-000064 · wf-form4_160010332328292.xml · nonDerivative · entry 1 DeLuca Teresa · CIK 0001685627 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,811 Read SEC document |
| August 10, 2020 Filed Aug 11, 2020 15:32 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | SaleCommon Stock | 5,317 | $20.60 | $109,530.20 |
DisclosureSEC source: 0001638833-20-000060 · wf-form4_159715995885043.xml · nonDerivative · entry 1 DeLuca Teresa · CIK 0001685627 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,811 Read SEC document |
| May 27, 2020 Filed May 29, 2020 15:06 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | GrantCommon Stock | 9,669 | $14.48 | $140,007.12 |
DisclosureSEC source: 0001638833-20-000053 · wf-form4_159076477051667.xml · nonDerivative · entry 1 DeLuca Teresa · CIK 0001685627 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,128 F1 · shares: Shares will vest on May 27, 2021. Read SEC document |
| September 06, 2019 Filed Sep 10, 2019 20:40 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | PurchaseCommon Stock | 1,000 | $6.65 | $6,650.00 |
DisclosureSEC source: 0001638833-19-000070 · wf-form4_156814803222858.xml · nonDerivative · entry 1 DeLuca Teresa · CIK 0001685627 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,459 Read SEC document |
| May 29, 2019 Filed May 31, 2019 20:49 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | GrantCommon Stock | 15,317 | $0.00 | $0.00 |
DisclosureSEC source: 0001638833-19-000051 · wf-form4_155933573339418.xml · nonDerivative · entry 1 DeLuca Teresa · CIK 0001685627 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,459 F1 · shares: Shares will vest on May 29, 2020. Read SEC document |
| August 24, 2018 Filed Aug 28, 2018 22:49 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | GrantCommon Stock | 7,865 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-18-000537 · edgar.xml · nonDerivative · entry 1 DeLuca Teresa · CIK 0001685627 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,142 Read SEC document |
| May 02, 2017 Filed May 4, 2017 20:57 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | GrantCommon Stock | 3,277 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-17-000326 · edgar.xml · nonDerivative · entry 1 DeLuca Teresa · CIK 0001685627 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,277 Read SEC document |
| September 30, 2016 Filed Sep 30, 2016 23:40 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | GrantStock Option (Right to Buy) · Derivative | 4,199 | $0.00 Strike: $20.24 | $0.00 |
DisclosureSEC source: 0000904454-16-001465 · edgar.xml · derivative · entry 1 DeLuca Teresa · CIK 0001685627 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,199 Underlying: Common Stock · 4,199 shares Expires 2026-09-30 F1 · derivative.exercise_date: The option vests annually over a three year period, with the first one-third vesting on 9/30/2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.